University Protests and Eli Lilly's Market News

This chapter delves into university challenges with protests and potential solutions, along with financial news on Eli Lilly's drug approvals and market reactions, including the impact of a diabetes drug approval in China and positive trial results for a Crohn's disease treatment. The conversation also assesses the competitive landscape in the pharmaceutical market and touches on the impending decision on a cryptocurrency ETF by the SEC impacting crypto prices.